Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1038/S41379-018-0152-1 | ||||
| Año | 2019 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Rosai-Dorfman disease is a rare histiocytic disorder shown to have gene mutations that activate the MAPK/ERK pathway in at least one-third of cases. Most patients with Rosai-Dorfman disease present with bulky lymphadenopathy or extranodal disease, but rarely Rosai-Dorfman disease is detected concomitantly with lymphoma in the same biopsy specimen. The underlying molecular mechanisms of focal Rosai-Dorfman disease occurring in the setting of lymphoma have not been investigated. We report 12 cases of Rosai-Dorfman disease and lymphoma involving the same anatomic site. There were five men and seven women (age, 23 to 77 years) who underwent lymph node (n = 11) or skin (n = 1) biopsy; the lymphomas included nodular lymphocyte predominant Hodgkin lymphoma (n = 6), classical Hodgkin lymphoma (n = 4), small lymphocytic lymphoma (n = 1) and extranodal marginal zone lymphoma (n = 1). The foci of Rosai-Dorfman disease in all cases had S100 protein-positive histiocytes undergoing emperipolesis. No patients had Rosai-Dorfman disease at other anatomic sites at initial diagnosis and at last follow-up (median, 40 months). We performed immunohistochemical analysis to assess activity of the MAPK/ERK pathway in the Rosai-Dorfman disease foci. We also micro-dissected disease foci and analyzed 146 genes using next-generation sequencing in four cases with adequate DNA; the panel included genes previously reported to be mutated in Rosai-Dorfman disease. All cases were negative for gene mutations. Nevertheless, all cases were positive for cyclin D1 and most cases showed p-ERK expression indicating that the MAPK/ERK pathway is active in the histiocytes of focal Rosai-Dorfman disease. We conclude that focal Rosai-Dorfman disease coexisting with lymphoma is a clinically benign and localized histiocytic proliferation. These data also indicate that the MAPK/ERK pathway is active in focal Rosai-Dorfman disease although we did not identify activating mutations. These findings suggest that the pathogenesis of focal Rosai-Dorfman disease is different from that of usual cases of Rosai-Dorfman disease.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Garces, Sofia | Mujer |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 2 | Yin, C. Cameron | - |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 3 | Patel, Keyur P. | - |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 4 | Khoury, Joseph D. | Hombre |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 5 | MANNING, JOHN T., JR. | Hombre |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 6 | Li, Shaoying | - |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 7 | Xu, Jie | - |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 8 | Pina-Oviedo, Sergio | Hombre |
Univ Arkansas Med Sci - Estados Unidos
University of Arkansas for Medical Sciences - Estados Unidos UAMS College of Medicine - Estados Unidos |
| 9 | Johnson, Malisha R. | - |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 10 | GONZALEZ-PROVIDELL, SERGIO | Hombre |
Pontificia Universidad Católica de Chile - Chile
Facultad de Medicina - Chile |
| 11 | Molgo, Montserrat | Mujer |
Pontificia Universidad Católica de Chile - Chile
Facultad de Medicina - Chile |
| 12 | Ruiz-Cordero, Roberto | Hombre |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |
| 13 | Medeiros, L. Jeffrey | - |
Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos The University of Texas MD Anderson Cancer Center - Estados Unidos |